DD April 12, 2011..
InfuSystem Holdings Announces Expiration of Warrants
MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.
InfuSystem is a leading provider of ambulatory infusion pumps to the outpatient oncology market as well as new and pre-owned infusion pumps and other biomedical equipment, and biomedical recertification, maintenance and repair services to hospitals, oncology practices and other alternate site health care providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support and operates Biomedical Service Centers of Excellence in Kansas City, Los Angeles and Toronto.
CONTACT: Investor Contact:
Pat LaVecchia
info@infusystem.com
Tel: (800) 962-9656
Media Contact:
David Haar
info@infusystem.com
Tel: (800) 962-9656
Source: InfuSystem, Inc.
InfuSystem Holdings Announces Expiration of Warrants
MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.
InfuSystem is a leading provider of ambulatory infusion pumps to the outpatient oncology market as well as new and pre-owned infusion pumps and other biomedical equipment, and biomedical recertification, maintenance and repair services to hospitals, oncology practices and other alternate site health care providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support and operates Biomedical Service Centers of Excellence in Kansas City, Los Angeles and Toronto.
CONTACT: Investor Contact:
Pat LaVecchia
info@infusystem.com
Tel: (800) 962-9656
Media Contact:
David Haar
info@infusystem.com
Tel: (800) 962-9656
Source: InfuSystem, Inc.
Recent INFU News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 04:56:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:45:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:31:11 PM
- InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026 • Business Wire • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:54:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2026 09:07:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 11:30:13 AM
- InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025 • Business Wire • 02/24/2026 11:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:20:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 11:36:07 AM
- InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 • Business Wire • 02/17/2026 11:30:00 AM
- Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026 • Business Wire • 12/10/2025 10:37:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 10:23:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:31:32 PM
- InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 • Business Wire • 11/10/2025 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2025 09:20:11 PM
- InfuSystem Reports Third Quarter 2025 Financial Results • Business Wire • 11/04/2025 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:28:54 AM
- InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025 • Business Wire • 10/28/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 08:08:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 09:23:03 PM
- InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025 • Business Wire • 09/25/2025 08:29:00 PM
